摘要
肝移植(liver transplantation,LT)是目前治疗原发性肝癌的最有效措施,尽管经过严格的选择标准,但术后常常发生复发,影响着患者的长期存活。据报道,肝移植术后复发(recurrence after liver transplantation)的发生率估计在6%～50%,并且在移植后的前两年中更常发生。本文就肝移植术后复发的多学科治疗策略进行综述。
Liver transplantation is currently the most effective treatment for primary liver cancer. Despite strict selection criteria, recurrence often occurs after surgery, which affects the long-term survival of patients. The incidence of recurrence after liver transplantation is reported to be estimated to be 6%- 50% and occurs more frequently in the first two years after transplantation. This article reviews the mufti- disciplinary treatment strategies for recurrence after liver transplantation.
作者
关智芬
陈伟强
GUAN Zhifen;CHEN Weiqiang(Guangdong Medical University Postgraduate College, Zhanjiang, Guangdong 524000, China ; 2 Department of Hepatobiliary Surgery, Zhongshan People＇s Hospital, Zhongshan, Guangdong 528400, China)
出处
《岭南现代临床外科》
2018年第5期589-592,598,共5页
Lingnan Modern Clinics in Surgery
关键词
肝癌
肝移植
术后复发
多学科治疗
liver cancer
liver transplantation
postoperative recurrence
multidisciplinary treatment
